Order Article Reprints

Marcé S, Méndez A, Xicoy B, Estrada N, Cabezón M, Sturla AL, García MR, Angona A, Amat P, Escribano Serrat S, et al. e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. Journal of Clinical Medicine. 2024; 13(3):779. https://doi.org/10.3390/jcm13030779

Marcé, Sílvia, Aleix Méndez, Blanca Xicoy, Natalia Estrada, Marta Cabezón, Antonella Luciana Sturla, Miriam Ratia García, Anna Angona, Paula Amat, Silvia Escribano Serrat, and et al. 2024. "e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response" Journal of Clinical Medicine 13, no. 3: 779. https://doi.org/10.3390/jcm13030779

Marcé, S., Méndez, A., Xicoy, B., Estrada, N., Cabezón, M., Sturla, A. L., García, M. R., Angona, A., Amat, P., Escribano Serrat, S., Scalzulli, E., Morgades, M., Senín, A., Hernández-Boluda, J. C., Ferrer-Marín, F., Anguita, E., Cortés, M., Plensa, E., Breccia, M., ... Zamora, L., on behalf of the Grupo Español de Leucemia Mieloide Crónica (GELMC). (2024). e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. Journal of Clinical Medicine, 13(3), 779. https://doi.org/10.3390/jcm13030779